Articles

Results 1 to 5 of 10
Most popular |Most recent


Galderma Labs L.P. v. Teva Pharms. USA, Inc.

USA - August 21 2019 The asserted claims of 1 ivermectin formulation are invalid on the basis of anticipation in light of a prior art reference that teaches application...

Oren D. Langer, Christopher A. Pinahs, Kelsey J. McElveen, Andrew J. Kabat.

INO Therapeutics LLC v. Praxair Distribution Inc.

USA - August 17 2019 But for a clerical error to be addressed on remand, the Federal Circuit affirms findings of ineligible subject matter and non-infringement....

Oren D. Langer, Christopher A. Pinahs, Kelsey J. McElveen, Andrew J. Kabat.

Amgen Inc. v. Amneal Pharms. LLC

USA - September 19 2019 The court denied defendant's motion to enforce its settlement agreement with plaintiff after the at-risk launch and subsequent settlement of another...

Oren D. Langer, Christopher A. Pinahs, Kelsey J. McElveen, Andrew J. Kabat.

Duke Univ. v. Akorn, Inc.

USA - September 16 2019 The court granted plaintiffs’ motion to dismiss Defendant’s antitrust and patent misuse counterclaims and related affirmative defenses....

Oren D. Langer, Christopher A. Pinahs, Kelsey J. McElveen, Andrew J. Kabat.

Sanofi-Aventis U.S., LLC v. Dr. Reddy’s Labs., Inc.

USA - August 14 2019 Plaintiff's disclaimer of claims found invalid by the PTAB mooted any controversy before the appellate court associated with that patent, and a...

Oren D. Langer, Christopher A. Pinahs, Kelsey J. McElveen, Andrew J. Kabat.